Department of Cardiovascular Diseases, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, 100091, China.
Chin J Integr Med. 2012 Jan;18(1):30-3. doi: 10.1007/s11655-011-0849-1. Epub 2011 Oct 12.
To investigate the effects of drug-containing serum of Chinese herbal compound, Xiongshao Capsule (, XS, for activating-blood) and Huanglian Capsule (, HL, for dispellingtoxin) on the oxidized low-density lipoprotein (ox-LDL)-induced inflammatory factors in human umbilical vein endothelial cells (HUVECs).
Thirty-two rats were randomly divided into four groups: the blank control group treated with distilled water, the positive control group treated with simvastatin (1.8 mg/kg), the test group I treated with Chinese herbal compound of XS (0.135 g/kg), and the test group II treated with Chinese herbal compound of XS (0.135 g/kg) and HL (0.135 g/kg). All the treatments were administered for 7 successive days by gastrogavage. Rats' blood serum was harvested 1 h after the last administration to prepare respective drugcontaining serum. HUVECs were exposed to ox-LDL (100 μg/mL) to induce cell injury model and incubated with corresponding drug-containing serum for 24 h. Untreated HUVECs were set for blank control. Levels of interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), and soluble intercellular adhesion molecule-1 (sICAM-1) in supernatant of cultured HUVECs were determined by enzyme-linked immunosorbent assay (ELISA). HUVEC surface expressions of ICAM-1 and E-selectin were determined by flow cytometry.
Levels of IL-6, TNF-α, and sICAM-1 in the supernatant of HUVECs as well as the cell surface expressions of ICAM-1 and E-selectin significantly increased after 24-h ox-LDL stimulation (P<0.01), while the abnormal elevations, except sICAM-1 in the test group I, were all reduced in the treated groups (the positive control and the two test groups) significantly (P<0.01 or P<0.05). Besides, the effect in the test group II seemed somewhat higher than that in the test group I but with no statistical significance (P>0.05).
Drug-containing serum of XS plus HL has a certain inhibitory effect on the vascular endothelial inflammation response induced by ox-LDL.
观察芎芍胶囊(XS)、黄连胶囊(HL)含药血清对氧化型低密度脂蛋白(ox-LDL)诱导的人脐静脉内皮细胞(HUVEC)炎症因子的影响。
32 只大鼠随机分为 4 组,空白对照组给予蒸馏水,阳性对照组给予辛伐他汀(1.8 mg/kg),XS 低、高剂量组分别给予 XS 含药血清(0.135 g/kg)和 XS 加 HL 含药血清(0.135 g/kg),每日 1 次灌胃给药,连续 7 天,末次给药 1 h 后腹主动脉采血制备含药血清。将 HUVEC 与 ox-LDL(100 μg/mL)共同孵育 24 h 建立细胞损伤模型,分别加入相应含药血清培养 24 h,设正常对照组(未加 ox-LDL)。采用酶联免疫吸附法(ELISA)检测细胞上清液中白细胞介素 6(IL-6)、肿瘤坏死因子-α(TNF-α)、可溶性细胞间黏附分子 1(sICAM-1)的含量,流式细胞术检测 HUVEC 表面细胞间黏附分子 1(ICAM-1)、E-选择素的表达。
ox-LDL 作用 24 h 后,HUVEC 上清液中 IL-6、TNF-α、sICAM-1 水平及细胞表面 ICAM-1、E-选择素表达均显著升高(P<0.01);各给药组上述异常升高均明显降低(P<0.01 或 P<0.05),其中 XS 加 HL 含药血清组 sICAM-1 水平降低更明显,但与 XS 高剂量组比较差异无统计学意义(P>0.05)。
XS 加 HL 含药血清对 ox-LDL 诱导的血管内皮炎症反应具有一定抑制作用。